Clinical Trials Browser

Not yet recruiting × Prostatic Neoplasms × enzalutamide × Clear all

NCT07104110 2025-08-05

Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Not yet recruiting

Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Phase 2 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms